• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单位关于未足月胎膜早破后保胎治疗的政策:与潜伏期、新生儿和 2 年结局的关系(EPICE 队列)。

Unit policies regarding tocolysis after preterm premature rupture of membranes: association with latency, neonatal and 2-year outcomes (EPICE cohort).

机构信息

EPIUnit - Institute of Public Health, University of Porto, Porto, Portugal.

Department of Mathematics and Applications, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.

出版信息

Sci Rep. 2020 Jun 12;10(1):9535. doi: 10.1038/s41598-020-65201-y.

DOI:10.1038/s41598-020-65201-y
PMID:32533019
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7293322/
Abstract

After preterm premature rupture of membranes (PPROM), antibiotics and antenatal steroids are effective evidence-based interventions, but the use of tocolysis is controversial. We investigated whether a unit policy of tocolysis use after PPROM is associated with prolonged gestation and improved outcomes for very preterm infants in units that systematically use these other evidence-based treatments. From the prospective, observational, population-based EPICE cohort study (all very preterm births in 19 regions from 11 European countries, 2011-2012), we included 607 women with a singleton pregnancy and PPROM at 24-29 weeks' gestation, of whom 101, 195 and 311 were respectively managed in 17, 32 and 45 units with no-use, restricted and liberal tocolysis policies for PPROM. The association between unit policies and outcomes (early-onset sepsis, survival at discharge, survival at discharge without severe morbidity and survival at two years without gross motor impairment) was investigated using three-level random-intercept logistic regression models, showing no differences in neonatal or two-year outcomes by unit policy. Moreover, there was no association between unit policies and prolongation of gestation in a multilevel survival analysis. Compared to a unit policy of no-use of tocolysis after PPROM, a liberal or restricted policy is not associated with improved obstetric, neonatal or two-year outcomes.

摘要

胎膜早破(PPROM)后,抗生素和产前类固醇是有效的循证干预措施,但抑制宫缩的使用存在争议。我们研究了在系统使用这些其他循证治疗方法的单位中,PPROM 后使用抑制宫缩的单位政策是否与延长胎龄和改善极早产儿的结局相关。这项研究来自前瞻性、观察性、基于人群的 EPICE 队列研究(11 个欧洲国家的 19 个地区所有极早产儿,2011-2012 年),共纳入了 607 名单胎妊娠和 24-29 周胎膜早破的孕妇,其中 17、32 和 45 个单位分别采取了不使用、限制和自由使用抑制宫缩的 PPROM 单位政策,分别有 101、195 和 311 名孕妇。采用三级随机截距逻辑回归模型研究单位政策与结局(早发性败血症、出院时存活率、出院时无严重发病率存活率和两年时无粗大运动障碍存活率)之间的关系,结果显示不同单位政策对新生儿或两年结局无差异。此外,在多水平生存分析中,单位政策与胎龄延长之间也没有关联。与不使用抑制宫缩的单位政策相比,自由或限制使用抑制宫缩的单位政策与改善产科、新生儿或两年结局无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/222a/7293322/6baba11e4438/41598_2020_65201_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/222a/7293322/eda757a7918f/41598_2020_65201_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/222a/7293322/6d19317978c4/41598_2020_65201_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/222a/7293322/6c225a0ac675/41598_2020_65201_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/222a/7293322/6baba11e4438/41598_2020_65201_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/222a/7293322/eda757a7918f/41598_2020_65201_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/222a/7293322/6d19317978c4/41598_2020_65201_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/222a/7293322/6c225a0ac675/41598_2020_65201_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/222a/7293322/6baba11e4438/41598_2020_65201_Fig4_HTML.jpg

相似文献

1
Unit policies regarding tocolysis after preterm premature rupture of membranes: association with latency, neonatal and 2-year outcomes (EPICE cohort).单位关于未足月胎膜早破后保胎治疗的政策:与潜伏期、新生儿和 2 年结局的关系(EPICE 队列)。
Sci Rep. 2020 Jun 12;10(1):9535. doi: 10.1038/s41598-020-65201-y.
2
Tocolysis in the management of preterm prelabor rupture of membranes at 22-33 weeks of gestation: study protocol for a multicenter, double-blind, randomized controlled trial comparing nifedipine with placebo (TOCOPROM).阿托西班在 22-33 孕周早产胎膜早破治疗中的应用:多中心、双盲、随机对照试验研究方案,比较硝苯地平与安慰剂(TOCOPROM)。
BMC Pregnancy Childbirth. 2021 Sep 8;21(1):614. doi: 10.1186/s12884-021-04047-2.
3
Preterm premature rupture of membranes at 22-25 weeks' gestation: perinatal and 2-year outcomes within a national population-based study (EPIPAGE-2).22-25 孕周胎膜早破:一项全国基于人群的研究(EPIPAGE-2)的围产儿和 2 年结局。
Am J Obstet Gynecol. 2018 Sep;219(3):298.e1-298.e14. doi: 10.1016/j.ajog.2018.05.029. Epub 2018 May 29.
4
Tocolytics for preterm premature rupture of membranes.用于胎膜早破的宫缩抑制剂。
Cochrane Database Syst Rev. 2014 Feb 27;2014(2):CD007062. doi: 10.1002/14651858.CD007062.pub3.
5
Tocolytics for preterm premature rupture of membranes.用于胎膜早破的宫缩抑制剂。
Cochrane Database Syst Rev. 2011 Oct 5(10):CD007062. doi: 10.1002/14651858.CD007062.pub2.
6
Tocolysis after preterm prelabor rupture of membranes and 5-year outcomes: a population-based cohort study.未足月胎膜早破后保胎治疗与 5 年结局:一项基于人群的队列研究。
Am J Obstet Gynecol. 2024 May;230(5):570.e1-570.e18. doi: 10.1016/j.ajog.2023.10.010. Epub 2023 Oct 11.
7
Nifedipine versus placebo in the treatment of preterm prelabor rupture of membranes: a randomized controlled trial: Assessment of perinatal outcome by use of tocolysis in early labor-APOSTEL IV trial.硝苯地平与安慰剂治疗胎膜早破早产:一项随机对照试验:早期分娩中使用宫缩抑制剂对围产期结局的评估-APOSTEL IV试验
Eur J Obstet Gynecol Reprod Biol. 2016 Oct;205:79-84. doi: 10.1016/j.ejogrb.2016.08.024. Epub 2016 Aug 9.
8
Tocolysis after preterm premature rupture of membranes and neonatal outcome: a propensity-score analysis.早产胎膜早破后保胎治疗与新生儿结局:倾向评分分析。
Am J Obstet Gynecol. 2017 Aug;217(2):212.e1-212.e12. doi: 10.1016/j.ajog.2017.04.015. Epub 2017 Apr 13.
9
Is there a role for tocolytic therapy during conservative management of preterm premature rupture of the membranes?在胎膜早破的保守治疗中,宫缩抑制剂疗法是否有作用?
Clin Obstet Gynecol. 2007 Jun;50(2):487-96. doi: 10.1097/GRF.0b013e31804c977d.
10
Antenatal magnesium sulfate for both tocolysis and fetal neuroprotection in premature rupture of the membranes before 32 weeks' gestation.妊娠32周前胎膜早破时,产前使用硫酸镁进行保胎和胎儿神经保护。
J Matern Fetal Neonatal Med. 2018 Jun;31(11):1431-1441. doi: 10.1080/14767058.2017.1317743. Epub 2017 Apr 26.

引用本文的文献

1
The microbiome biomarkers of pregnant women's vaginal area predict preterm prelabor rupture in Western China.中国西部地区孕妇阴道微生物组生物标志物可预测早产先兆破裂。
Front Cell Infect Microbiol. 2024 Oct 31;14:1471027. doi: 10.3389/fcimb.2024.1471027. eCollection 2024.
2
Tocolysis in the management of preterm prelabor rupture of membranes at 22-33 weeks of gestation: study protocol for a multicenter, double-blind, randomized controlled trial comparing nifedipine with placebo (TOCOPROM).阿托西班在 22-33 孕周早产胎膜早破治疗中的应用:多中心、双盲、随机对照试验研究方案,比较硝苯地平与安慰剂(TOCOPROM)。
BMC Pregnancy Childbirth. 2021 Sep 8;21(1):614. doi: 10.1186/s12884-021-04047-2.

本文引用的文献

1
[Modalities of birth in case of uncomplicated preterm premature rupture of membranes: CNGOF Preterm Premature Rupture of Membranes Guidelines].[胎膜早破无并发症情况下的分娩方式:法国国家妇产科和生殖医学学会胎膜早破指南]
Gynecol Obstet Fertil Senol. 2018 Dec;46(12):1068-1075. doi: 10.1016/j.gofs.2018.10.021. Epub 2018 Oct 30.
2
[Epidemiology, risk factors and child prognosis: CNGOF Preterm Premature Rupture of Membranes Guidelines].[流行病学、危险因素与儿童预后:CNGOF胎膜早破指南]
Gynecol Obstet Fertil Senol. 2018 Dec;46(12):1004-1021. doi: 10.1016/j.gofs.2018.10.019. Epub 2018 Oct 29.
3
Preterm premature rupture of the membranes.
胎膜早破(早产)
Obstet Gynecol. 2003 Jan;101(1):178-93. doi: 10.1016/s0029-7844(02)02366-9.
4
Oral ritodrine and preterm premature rupture of membranes.口服利托君与胎膜早破
Obstet Gynecol. 1985 Nov;66(5):621-3.